David L. Corbet

70 year

Health Technology

Profile

David L.
Corbet has been President, Chief Operating Officer and a Director of Matritech, Inc. since October 1993.
He joined Matritech as Executive Vice President in April 1993.
Prior to joining Matritech, Mr. Corbet was President and Chief Operating Officer of T Cell Diagnostics, Inc. from 1991 to April 1993.

Former positions of David L. Corbet

Companies	Position	End
MZT Holdings, Inc. MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.	Director/Board Member	20/06/2012
Matritech, Inc. Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services	President	-

See the detail of David L. Corbet's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David L. Corbet's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Matritech, Inc. Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services	Health Technology
MZT Holdings, Inc. MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA.	Health Technology